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CREATING A CULTURE OF ONGOING LEARNING
Frith, J.L.1, Adler, A.2 1Duke University, Durham, NC; 2Duke Univer-
sity, Durham, NC
Orientation programs exist for nurses in all clinical areas. For
the hematopoietic stem cell transplant (HSCT) specialty, an ex-
tensive orientation program has been developed for newer nurses
to obtain a wealth of knowledge within the specialty. In the
HSCT day hospital, the turnover rate is historically very low.
While nurses were oriented upon initial employment, continuing
educational opportunities were miminal, as the day hospital is
off-site from the academic center. It was evident that employees
were unaware and felt unable to attend continuing education due
to the staffing challenges.
As transplants are better understood, and utilized in patients
with different disease processes and more comorbidities, the acu-
ity becomes higher in the outpatient environment. It is therefore
imperative that nurses are prepared to critically care for this
more acutely ill patient population through assessment and ap-
propriate interventions. A HSCT nurse education program was
developed for the outpatient staff to include opportunities for
nurses to obtain specific needed education to maintain compe-
tence on current care and issues within HSCT. In developing
the program, education style and preference were assessed. The
Nurse Manager reviewed courses offered through the health sys-
tem and determined courses that were relevant for each nurse to
take. The Clinical Nurse Specialist provided insight into the
long-term vision of the HSCT program. Developing a successful
ongoing education program for experienced nurses that engages
the nurses is vital to the success of this unique clinic.
Thirty classes were identified as necessary for continued compe-
tence. Prior to scheduling staff for continuing education 31% of
the classes had been attended within the past 5 years. In advance,
scheduling was accommodated to ensure staff was able to attend clas-
ses away from work. Since implementation (6 months ago), 42% of
the classes has been attended with staff reporting appreciation of
the opportunities offered. The staff has expressed a rejuvenated in-
terest in continuing education, and is now exploring further oppor-
tunities on their own. This has also translated into staff being more
aware, and providing further evidenced-based education to patients
and their caregivers. Nurses that are involved, engaged, and take
ownership of their education will have a positive effect on their en-
vironment and others. Having nurses and leadership involved will
help create a culture of ongoing learning.517
INCREASE HCAHPS SCORES IN AUTOLOGOUS STEM CELL TRANSPLANT
PATIENTS AT CLEVELAND CLINIC
Cherni, K., Ferraro, C., Green, G., Weber, C., Kalaycio, M. Cleveland
Clinic, Cleveland, OH
The Bone Marrow Transplant (BMT) Program at Cleveland
Clinic (CC) prides itself with a ‘Patients First’ mantra.We have built
a multidisciplinary staff to support and educate patients throughout
their transplant process. Education binders are mailed to patients af-
ter their consult with a transplant physician. This binder contains ed-
ucational material to assist patients and caregivers throughout the
transplant process. The BMT nurse coordinators meet with patients
and caregivers many times during the transplant process to educate,
review and reinforce the educational material.
Prior to discharge, patients and caregivers have always been edu-
cated about post-transplant care, including the use of medications
for symptom management. We recently chose to improve the pro-
cess of medication communication to improve patient safety and sat-
isfaction.
Beginning July 7th, 2011 the following changes were made to our
autologous discharge protocol: 1) The BMT PharmD creates and
reviews with the patient and family, a ‘MedAction’ form that in-
cludes each discharge medication. The form includes generic and
brand names, dose, frequency, and the rationale for each medica-
tion. Medications for symptom management, often prescribed ‘as
needed’, are especially important and often the directions can beconfusing for patients. 2) Caregivers obtain discharge medications
from the pharmacy to allow the PharmD and the inpatient nurse
to’re-review’ the actual dispensed medication. These changes will
help decrease confusion about new medications and should increase
medication communication and compliance. 3) Autologous BMT
patients are to be scheduled in the outpatient clinic for labs and
possible treatment 2-3 days after discharge in lieu of having labs
drawn near home. This gives patients and their nurse an opportu-
nity to assess symptoms, discuss questions and concerns, and to re-
view medications.
Table. Hospital Consumer Assessment of Healthcare Pro-
viders and Systems (HCAHPS) Scores for BMT Unit
Cleveland Clinic2007 2008 2009 2010July and
August 2011Goal thru 3rd
Quarter 2011Medication
Communication71% 63% 65% 70% 75% 68%Hospital Environment 55% 47% 60% 64% 67% NAResponsiveness 49% 58% 62% 67% 68% 73%Nurse
Communication86% 79% 82% 81% 79% 81%Doctor
Communication86% 74% 81% 73% 73% 86%Discharge 87% 89% 97% 94% 92% 88%Pain Management 78% 73% 78% 71% 72% 76%Overall Assessment 79% 64% 86% 80% 79% 80%As indicated in the table, our HCAHPS scores for medical com-
munication have increased from 70% to 75% since our plan was im-
plemented. The table displays the percentage of respondents who
reply ‘‘Always’’ to the question about medical communication in
the survey instrument.
We conclude that multidisciplinary process improvements to
patient instructions and education improve patient satisfaction as
reflected in post-discharge surveys.518
RITUXIMAB AND PPE: TO WEAR OR NOT TO WEAR? THAT IS THE
QUESTION
Brown, S.L. MD Anderson Cancer Center, Houston, TX
On the stem cell transplant (SCT) unit of a large comprehen-
sive cancer center, current policy requires staff wear personal
protective equipment (PPE) when administering drugs considered
hazardous by Centers for Disease Control (CDC) and National
Institute for Occupational Safety and Health (NIOSH) guide-
lines. Rituximab, a monoclonal antibody drug used as part of
conditioning regimens for stem cell transplantation, falls under
these guidelines. Each dose is administered over 4 to 8 hours
and requires extensive monitoring, including frequent vital signs,
rate changes, and assessment of the patient. Adorning PPE each
time the nurse enters a patient’s room becomes both time con-
suming and costly.
To address this issue, a group of nurses developed an evidenced-
based work group to evaluate if the use of PPE was necessary
when administering Rituximab. The group consulted the literature,
obtained data on the cost of PPE, average infusion times, and iden-
tified the average number of times a room was entered during Ritux-
imab administration.
The group found the average length of infusion was 4.8 hours,
with 18.5 approaches, and the use of 1.7 chemotherapy/biother-
apy gowns. The average cost of PPE per administration is
$75.98, not considering specific isolation restrictions or the
need to enter the room more often. Reviewing the literature,
CDC and NIOSH guidelines revealed that Rituximab is not con-
sidered a hazardous drug and has no adverse health effects
through eye, skin, or mucous membrane contact (Genentech,
2011). In fact, the Genentech Company, producer of Rituximab,
reports no special first aid measures are required after exposure
of the drug except hand washing.
